Beskind Daniel L, Rhodes Suzanne Michelle, Stolz Uwe, Birrer Brett, Mayfield Thomas R, Bourn Scott, Denninghoff Kurt
Prehosp Emerg Care. 2014 Jul-Sep;18(3):433-41. doi: 10.3109/10903127.2013.864358. Epub 2014 Jan 24.
Seizure is a frequent reason for activating the Emergency Medical System (EMS). Little is known about the frequency of seizure caused by hypoglycemia, yet many EMS protocols require glucose testing prior to treatment. We hypothesized that hypoglycemia is rare among EMS seizure patients and glucose testing results in delayed administration of benzodiazepines.
This was a retrospective study of a national ambulance service database encompassing 140 ALS capable EMS systems spanning 40 states and Washington DC. All prehospital calls from August 1, 2010 through December 31, 2012 with a primary or secondary impression of seizure that resulted in patient treatment or transport were included. Median regression with robust and cluster (EMS agency) adjusted standard errors was used to determine if time to benzodiazepine administration was significantly related to blood glucose testing.
Of 2,052,534 total calls, 76,584 (3.7%) were for seizure with 53,505 (69.9%) of these having a glucose measurement recorded. Hypoglycemia (blood glucose <60 mg/dL) was present in 638 (1.2%; CI: 1.1, 1.3) patients and 478 (0.9%; CI: 0.8, 1.0) were treated with a glucose product. A benzodiazepine was administered to 73 (11.4%; CI: 9.0, 13.9) of the 638 hypoglycemic patients. Treatment of seizure patients with a benzodiazepine occurred in 6,389 (8.3%; CI: 8.1, 8.5) cases and treatment with a glucose product occurred in 975 (1.3%; CI: 1.2, 1.4) cases. Multivariable median regression showed that obtaining a blood glucose measurement prior to benzodiazepine administration compared to no glucose measurement or glucose measurement after benzodiazepine administration was independently associated with a 2.1 minute (CI: 1.5, 2.8) and 5.9 minute (CI: 5.3, 6.6) delay to benzodiazepine administration by EMS, respectively.
Rates of hypoglycemia were very low in patients treated by EMS for seizure. Glucose testing prior to benzodiazepine administration significantly increased the median time to benzodiazepine administration. Given the importance of rapid treatment of seizure in actively seizing patients, measurement of blood glucose prior to treating a seizure with a benzodiazepine is not supported by our study. EMS seizure protocols should be revisited.
癫痫发作是启动紧急医疗系统(EMS)的常见原因。关于低血糖引起癫痫发作的频率知之甚少,但许多EMS协议要求在治疗前进行血糖检测。我们假设低血糖在EMS癫痫患者中很少见,且血糖检测会导致苯二氮䓬类药物给药延迟。
这是一项对全国救护车服务数据库的回顾性研究,该数据库涵盖了40个州和华盛顿特区的140个具备高级生命支持(ALS)能力的EMS系统。纳入了2010年8月1日至2012年12月31日期间所有因癫痫发作作为主要或次要诊断而导致患者接受治疗或转运的院前呼叫。采用具有稳健和聚类(EMS机构)调整标准误差的中位数回归来确定苯二氮䓬类药物给药时间是否与血糖检测显著相关。
在总共2,052,534次呼叫中,76,584次(3.7%)是因癫痫发作,其中53,505次(69.9%)记录了血糖测量值。638名(1.2%;置信区间:1.1, 1.3)患者存在低血糖(血糖<60 mg/dL),478名(0.9%;置信区间:0.8, 1.0)患者接受了葡萄糖产品治疗。638名低血糖患者中有73名(11.4%;置信区间:9.0, 13.9)接受了苯二氮䓬类药物治疗。6,389例(8.3%;置信区间:8.1, 8.5)癫痫患者接受了苯二氮䓬类药物治疗,975例(1.3%;置信区间:1.2, 1.4)患者接受了葡萄糖产品治疗。多变量中位数回归显示,与未进行血糖测量或在苯二氮䓬类药物给药后进行血糖测量相比,在苯二氮䓬类药物给药前进行血糖测量分别与EMS苯二氮䓬类药物给药延迟2.1分钟(置信区间:1.5, 2.8)和5.9分钟(置信区间:5.3, 6.6)独立相关。
EMS治疗的癫痫患者中低血糖发生率非常低。在苯二氮䓬类药物给药前进行血糖检测显著增加了苯二氮䓬类药物给药的中位时间。鉴于对正在发作的癫痫患者进行快速治疗的重要性,我们的研究不支持在使用苯二氮䓬类药物治疗癫痫前测量血糖。应重新审视EMS癫痫发作协议。